Balaņa, Carmen <br/><br/>
Pseudoprogression as an adverse event of glioblastoma therapy.  [electronic resource] 

 -  Cancer medicine  Dec 2017 
 - 2858-2866 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>2045-7634 
<br/><br/><label>Standard No.: </label>10.1002/cam4.1242  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--genetics<br/>Brain Neoplasms--diagnostic imaging<br/>Chi-Square Distribution<br/>DNA Methylation<br/>DNA Modification Methylases--genetics<br/>DNA Repair Enzymes--genetics<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Glioblastoma--diagnostic imaging<br/>Humans<br/>Kaplan-Meier Estimate<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Odds Ratio<br/>Polymerase Chain Reaction<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Retrospective Studies<br/>Risk Factors<br/>Spain<br/>Time Factors<br/>Treatment Outcome<br/>Tumor Suppressor Proteins--genetics<br/>Young Adult